nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Current barriers, challenges and opportunities for the development of effective STI vaccines: Point of view of vaccine producers, biotech companies and funding agencies
|
Dodet, Betty |
|
2014 |
32 |
14 |
p. 1624-1629 6 p. |
artikel |
2 |
Current status and prospects for development of an HSV vaccine
|
Johnston, Christine |
|
2014 |
32 |
14 |
p. 1553-1560 8 p. |
artikel |
3 |
Current status and prospects for development of a vaccine against Trichomonas vaginalis infections
|
Smith, Jeffrey |
|
2014 |
32 |
14 |
p. 1588-1594 7 p. |
artikel |
4 |
Current status of syphilis vaccine development: Need, challenges, prospects
|
Cameron, Caroline E. |
|
2014 |
32 |
14 |
p. 1602-1609 8 p. |
artikel |
5 |
Development status and future prospects for a vaccine against Chlamydia trachomatis infection
|
Hafner, Louise M. |
|
2014 |
32 |
14 |
p. 1563-1571 9 p. |
artikel |
6 |
Editorial Board/Aims and Scope
|
|
|
2014 |
32 |
14 |
p. CO2- 1 p. |
artikel |
7 |
Health care professional communication about STI vaccines with adolescents and parents
|
Hofstetter, Annika M. |
|
2014 |
32 |
14 |
p. 1616-1623 8 p. |
artikel |
8 |
HPV vaccines to prevent cervical cancer and genital warts: an update
|
Dochez, Carine |
|
2014 |
32 |
14 |
p. 1595-1601 7 p. |
artikel |
9 |
Microbiome, sex hormones, and immune responses in the reproductive tract: Challenges for vaccine development against sexually transmitted infections
|
Brotman, Rebecca M. |
|
2014 |
32 |
14 |
p. 1543-1552 10 p. |
artikel |
10 |
Preface
|
Temmerman, Marleen |
|
2014 |
32 |
14 |
p. 1523-1524 2 p. |
artikel |
11 |
Summary and recommendations from a National Institute of Allergy and Infectious Diseases (NIAID) workshop on “Next Generation Herpes Simplex Virus Vaccines”
|
Knipe, David M. |
|
2014 |
32 |
14 |
p. 1561-1562 2 p. |
artikel |
12 |
The STI vaccine roadmap—A long overdue intervention
|
Rees, Helen |
|
2014 |
32 |
14 |
p. 1638-1639 2 p. |
artikel |
13 |
The theoretical impact and cost-effectiveness of vaccines that protect against sexually transmitted infections and disease
|
Garnett, Geoff P. |
|
2014 |
32 |
14 |
p. 1536-1542 7 p. |
artikel |
14 |
Toward global prevention of sexually transmitted infections (STIs): The need for STI vaccines
|
Gottlieb, Sami L. |
|
2014 |
32 |
14 |
p. 1527-1535 9 p. |
artikel |
15 |
Towards a safe and effective chlamydial vaccine: Lessons from the eye
|
Mabey, David C.W. |
|
2014 |
32 |
14 |
p. 1572-1578 7 p. |
artikel |
16 |
Vaccines against gonorrhea: Current status and future challenges
|
Jerse, Ann E. |
|
2014 |
32 |
14 |
p. 1579-1587 9 p. |
artikel |
17 |
Vaccines against sexually transmitted infections: The way forward
|
Broutet, Nathalie |
|
2014 |
32 |
14 |
p. 1630-1637 8 p. |
artikel |
18 |
Vaccines for sexually transmitted infections: Past, present and future
|
Fruth, Uli |
|
2014 |
32 |
14 |
p. 1525-1526 2 p. |
artikel |
19 |
Vaccines to promote and protect sexual health: Policy challenges and opportunities
|
Hawkes, Sarah |
|
2014 |
32 |
14 |
p. 1610-1615 6 p. |
artikel |